Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction

Abstract

Excessive accumulation of triglycerides (TG) in liver, in the absence of significant alcohol consumption is nonalcoholic fatty liver disease (NAFLD). NAFLD is a significant risk factor for developing cirrhosis and an independent predictor of cardiovascular disease. High fructose corn syrup (HFCS)-containing beverages were associated with metabolic abnormalities, and contributed to the development of NAFLD in human trials. Ingested carbohydrates are a major stimulus for hepatic de novo lipogenesis (DNL) and are more likely to directly contribute to NAFLD than dietary fat. Substrates used for the synthesis of newly made fatty acids by DNL are primarily glucose, fructose, and amino acids. Epidemiological studies linked HFCS consumption to the severity of fibrosis in patients with NAFLD. New animal studies provided additional evidence on the role of carbohydrate-induced DNL and the gut microbiome in NAFLD. The excessive consumption of HFCS-55 increased endoplasmic reticulum stress, activated the stress-related kinase, caused mitochondrial dysfunction, and increased apoptotic activity in the liver. A link between dietary fructose intake, increased hepatic glucose transporter type-5 (Glut5) (fructose transporter) gene expression and hepatic lipid peroxidation, MyD88, TNF-α levels, gut-derived endotoxemia, toll-like receptor-4, and NAFLD was reported. The lipogenic and proinflammatory effects of fructose appear to be due to transient ATP depletion by its rapid phosphorylation within the cell and from its ability to raise intracellular and serum uric acid levels. However, large prospective studies that evaluated the relationship between fructose and NAFLD were not performed yet.

Keywords: Nonalcoholic fatty liver disease (NAFLD); carbohydrate; de novo lipogenesis (DNL); high fructose corn syrup (HFCS).

Figures

Figure 1

Increased consumption of sugar-sweetened beverages and pre-packaged foods is related to the risk of metabolic syndrome. High fructose corn syrup (HFCS) stimulates de novo lipogenesis and finally development of nonalcoholic fatty liver disease (NAFLD) & nonalcoholic steatohepatitis (NASH).

Figure 2

Fructose is poorly absorbed from the gastrointestinal tract by the glucose transporter type-5 (GLUT-5) transporter. Glucose is transported into cells by GLUT-4, an insulin-dependent transport system. Fructose is almost entirely cleared by the liver (the circulating concentration is ~0.01 mmol/L in peripheral blood, compared with 5.5 mmol/L for glucose). Hepatic metabolism of fructose induces de novo lipogenesis. Fructose phosphorylation in the liver consumes ATP, consequently the accumulated ADP serves as substrate for uric acid formation.

Figure 3

Fructose ingestion can rapidly cause fatty liver in animals by the development of leptin resistance, reduced plasma insulin and leptin concentrations and not suppress circulating ghrelin. HFCS, high fructose corn syrup; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis.